[PDF][PDF] Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study

AT Stopeck, A Lipton, JJ Body… - Journal of clinical …, 2010 - prostatehealthed.org
AT Stopeck, A Lipton, JJ Body, GG Steger, K Tonkin, RH De Boer, M Lichinitser, Y Fujiwara…
Journal of clinical oncology, 2010prostatehealthed.org
Purpose This randomized study compared denosumab, a fully human monoclonal antibody
against receptor activator of nuclear factor B (RANK) ligand, with zoledronic acid in delaying
or preventing skeletal-related events (SREs) in patients with breast cancer with bone
metastases.
Purpose
This randomized study compared denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor B (RANK) ligand, with zoledronic acid in delaying or preventing skeletal-related events (SREs) in patients with breast cancer with bone metastases.
prostatehealthed.org